Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial | ADC Fetal & Neonatal Edition

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Original research

Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial

Online download statistics by month:

Online download statistics by month: August 2022 to September 2024

	Abstract	Full	Pdf
Aug 2022	351	358	141
Sep 2022	2175	2167	694
Oct 2022	1051	1056	372
Nov 2022	548	541	148
Dec 2022	448	453	121
Jan 2023	580	590	94
Feb 2023	912	912	174
Mar 2023	1053	1058	225
Apr 2023	729	727	173
May 2023	492	495	151
Jun 2023	412	415	107
Jul 2023	529	532	78
Aug 2023	340	345	86
Sep 2023	413	416	79
Oct 2023	443	435	95
Nov 2023	637	644	96
Dec 2023	461	464	125
Jan 2024	152	135	276
Feb 2024	384	382	104
Mar 2024	820	809	145
Apr 2024	970	954	162
May 2024	688	687	97
Jun 2024	526	528	127
Jul 2024	662	654	145
Aug 2024	444	434	82
Sep 2024	492	486	100
Total	16712	16677	4197